[1]陈长军, 徐为华, 张梦晨, 等. 七叶皂苷药理活性及制剂临床应用研究进展[J]. 武汉大学学报(医学版), 2020, 41(1): 157-163.
[2]WANG T, FU F, ZHANG L, et al. Effects of escin on acute inflammation and the immune system in mice[J]. Pharmacol Rep, 2009, 61(4): 697‑704.
[3]ZHANG L, WANG H, FAN H, et al. The potent anti‑inflammatory agent escin does not increase corticosterone secretion and immune cell apoptosis in mice[J]. Fitoterapia, 2011, 82(6): 861‑867.
[4]CHENG Y, WANG H, MAO M, et al. Escin increases the survival rate of LPS‑induced septic mice through inhibition of HMGB1 release from macrophages[J]. Cell Physiol Biochem, 2015, 36(4): 1577‑1586.
[5]XIN W, ZHANG L, FAN H, et al. Escin attenuates acute lung injury induced by endotoxin in mice[J]. Eur J Pharm Sci, 2011, 42(1‑2): 73‑80.
[6]ZHAO S Q, XU S Q, CHENG J, et al. Anti-inflammatory effect of external use of escin on cutaneous inflammation: possible involvement of glucocorticoids receptor[J]. Chin J Nat Med, 2018, 16(2): 105‑112.
[7]ZHANG F L. Protective effect of escinin and Triamcinolone on blood-retinal barrier injury and its mechanism[D]. Jinan: Shandong University, 2013.
[8]ZHANG F, LI Y, ZHANG L, et al. Synergistic protective effects of escin and lowdose glucocorticoids on bloodretinal barrier breakdown in a rat model of retinal ischemia[J]. Mol Med Rep, 2013, 7(5): 1511‑1515.
[9]SIPOS W, REUTTERER B, FRANK M, et al. Escin inhibits type Ⅰ allergic dermatitis in a novel porcine model[J]. Int Arch Allergy Immunol, 2013, 161(1): 44‑52.
[10]LINDNER I, MEIER C, URL A, et al. Beta-escin has potent anti‑allergic efficacy and reduces allergic airway inflammation[J]. BMC Immunol, 2010, 11: 24.